Supply and demand my friend. As competitors enter the market, discounts are inevitable. Until then, pricing will hold.
Welcome to GildWorld where up is down and down is up.
How about the lawsuits over testosterone drugs that ABBV over-marketed. IMO, the exposure is high given the number of patients and seriousness of the harm. Thoughts?
Thanks for the deep analysis that accompanied your predictions. Pure unsubstantiated speculation.